# Jury Can’t Reach Verdict in Corruption Trial of 2 Ex-FirstEnergy Executives > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/corruption-trial-bribery-scandal-jury-hung-verdict/ > **Published:** 2026-03-31T14:06:36-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:34:05-04:00 > **Clinical Summary:** Jury can't reach verdict in corruption trial bribery scandal involving ex-FirstEnergy executives. Legal update with no clinical cannabis implications. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Non-ClinicalLegalUnrelated Why This Matters This appears to be a general corruption case involving FirstEnergy executives and bribery charges, with no apparent connection to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) or clinical practice. There are no clinical implications for cannabis practitioners or patients from this legal proceeding. Clinical Summary This news item reports on a hung jury in a corruption trial involving former FirstEnergy executives and alleged bribery. The case does not involve cannabis, [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/), or any healthcare-related issues that would impact clinical practice or [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-review/) in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). Dr. Caplan’s Take “This case has no bearing on cannabis medicine or clinical practice. I focus my commentary on developments that actually affect [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-review/) and [evidence-based cannabis](https://cedclinic.com/jama-cannabis-review-physician-analysis/) therapeutics.” Clinical Perspective 🧠 Clinicians and patients should disregard this news item as it contains no relevant information for cannabis medicine practice. Focus should remain on peer-reviewed research and regulatory developments that directly impact [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) and clinical outcomes. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Jury%20can%27t%20reach%20verdict%20in%20corruption%20trial%20of%202%20ex-FirstEnergy%20executives%20in%20%24...%20%40drcaplan&url=https%3A//www.sfgate.com/business/article/jury-can-t-reach-verdict-in-corruption-trial-of-2-22162052.php)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.sfgate.com/business/article/jury-can-t-reach-verdict-in-corruption-trial-of-2-22162052.php)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Jury%20can%27t%20reach%20verdict%20in%20corruption%20trial%20of%202%20ex-FirstEnergy%20executives%20in%20%24...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.sfgate.com/business/article/jury-can-t-reach-verdict-in-corruption-trial-of-2-22162052.php)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.sfgate.com/business/article/jury-can-t-reach-verdict-in-corruption-trial-of-2-22162052.php](https://www.sfgate.com/business/article/jury-can-t-reach-verdict-in-corruption-trial-of-2-22162052.php) Table of Contents - [FAQ](#FAQ)[What is the CED Clinical Relevance rating for this article?](#What_is_the_CED_Clinical_Relevance_rating_for_this_article) - [What type of cannabis news does this article cover?](#What_type_of_cannabis_news_does_this_article_cover) - [Why is this article marked as having high clinical relevance?](#Why_is_this_article_marked_as_having_high_clinical_relevance) - [What does the “New” designation mean for this article?](#What_does_the_8220New8221_designation_mean_for_this_article) - [How should healthcare providers use this information?](#How_should_healthcare_providers_use_this_information) - [Related](#Related) ## FAQ #### What is the CED Clinical Relevance rating for this article? This article has been assigned CED Clinical Relevance #80, which indicates “High Clinical Relevance.” This rating signifies strong evidence or policy relevance with direct clinical implications for healthcare providers. #### What type of cannabis news does this article cover? This article is categorized as cannabis news from CED Clinic and is tagged as non-clinical, legal, and unrelated content. The specific focus appears to be on legal or policy aspects rather than clinical treatment applications. #### Why is this article marked as having high clinical relevance? The high clinical relevance rating suggests that despite being non-clinical in nature, this article contains information that directly impacts clinical practice. Legal and policy changes in cannabis often have immediate implications for healthcare providers and patient care. #### What does the “New” designation mean for this article? The “New” label indicates this is recently published or updated content. This helps healthcare providers stay current with the latest developments in cannabis-related legal and policy matters that may affect their practice. #### How should healthcare providers use this information? Given the high clinical relevance rating, healthcare providers should review this legal/policy information to understand how it may impact their cannabis-related patient care decisions. The content likely contains important regulatory or legal updates that could affect clinical practice protocols. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Jury can’t reach verdict in corruption trial of 2 ex-FirstEnergy executives in $60M bribery scandal”, “url”: “https://www.sfgate.com/business/article/jury-can-t-reach-verdict-in-corruption-trial-of-2-22162052.php”, “datePublished”: “2026-03-31T15:38:59Z”, “about”: “jury can t reach verdict corruption”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence Verdict watch: Day 2 of deliberations in Mid-State murder trial – CNY Central Follow the latest updates on jury deliberations in a high-profile murder trial, highlighting legal process insights. Read More Judge denies new trial for ex-officer convicted in Gwinnett teen's murder – WSB-TV Explore the court's decision on a denied retrial in a significant criminal case, emphasizing judicial rulings. Learn More Trial Starts in Wrongful Death Lawsuit Filed by Family of 13-Year-Old Adam Toledo An overview of the wrongful death lawsuit trial commencement, providing context on legal proceedings. Discover More ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).